François Devin
About
In The Last Decade
François Devin
26 papers receiving 406 citations
Peers
Comparison fields: 5 of 45
- Ophthalmology 346
- Radiology, Nuclear Medicine and Imaging 306
- Molecular Biology 119
- Neurology 53
- Oncology 13
Countries citing papers authored by François Devin
This map shows the geographic impact of François Devin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Devin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Devin more than expected).
Fields of papers citing papers by François Devin
This network shows the impact of papers produced by François Devin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Devin. The network helps show where François Devin may publish in the future.
Co-authorship network of co-authors of François Devin
This figure shows the co-authorship network connecting the top 25 collaborators of François Devin. A scholar is included among the top collaborators of François Devin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Devin. François Devin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 3 | |
| 7 | 4 | |
| 8 | 114 | |
| 9 | 4 | |
| 10 | Switch from aflibercept to ranibizumab: Up to 2 years follow-up post View2 study | 1 |
| 11 | 59 | |
| 12 | 17 | |
| 13 | Phase I MP0112 Wet AMD Study Imaging Results: Darpin® MP0112 Shows Potential For Quarterly Dosing In Wet AMD | 3 |
| 14 | Phase I Mp0112 Wet AMD Study: Results Of A Single Escalating Dose Study With DARPin® MP0112 In Wet AMD | 9 |
| 15 | 20 | |
| 16 | 74 | |
| 17 | 12 | |
| 18 | 8 | |
| 19 | 18 | |
| 20 | [Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases]. | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.